Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > This is the Week
View:
Post by Bunge on Mar 14, 2021 3:06pm

This is the Week

Similar to the 52 weeks of 2 weeks to "flatten the curve"...

On this the 416th week of "this is the Week"...

This REALLY is the week... I CAN FEEL IT!

User image
Comment by Longholder99 on Mar 14, 2021 3:14pm
One of these days Norton. You will be correct. Love that the FDA is making results king. Means that when the immuno franken drugs get shelved. The value of TLT's real results just got that much pricier.
Comment by CancerSlayer on Mar 14, 2021 10:17pm
  That's for sure LH.  I haven't felt more confident since Keytruda set the low bar with a 19% durable response rate.  I think we all know that % is surmountable.  But I think much of the market fails to realize the full value of our ACT.  It can not only potentially "replace" primary or SOC treatments, but I believe it has equal (if not greater ...more  
Comment by tamarindo1 on Mar 15, 2021 3:22pm
We only have to be right once. :-)
Comment by robertshaw on Mar 14, 2021 3:54pm
Even if this is not the week, we could get one more week to load up the cheapies, thanks to the manipulation of Blowjobjoe's boss.
Comment by Sunvalley on Mar 15, 2021 9:01am
No , I dont think that this is the week because all I can "feel" is the humongous bowl of hot chile that I had in the middle of the night. Gives a new meaning to the word "feel" believe me.
Comment by 99942Apophis on Mar 15, 2021 9:16am
Sunvalley might be a little late, try porridge it will dilute some of that (ring of burning fire) you're not alone in late night poor food choices lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250